The “What Ifs” of WM: Adopting a Positive Mindset
with Deborah KellyThursday, January 22nd at 12pm ET What if it works out? What if it’s all ok? What if something good happens in spite of your WM diagnosis? In this interactive webinar, we’ll meet an inspiring mother of 4 who was diagnosed with Waldenstrom at age 37....
The Joy of Music
with Declan CosgroveThursday, Dec 11th at 1pm EST / 6pm GMT There is a strong link between music and physical and mental health. Music can influence hormones, reduce stress, and improve mood. Just listening to music is very restorative – but playing music is...
NORD Breakthrough Summit 2025
From VOICES to BREAKTHROUGHS NORD® Breakthrough Summit 2025 October 19–21 | Washington, DC With Cyndi Powers, CMP This past week, I had the privilege of attending the NORD® Breakthrough Summit in Washington, DC, for the third time. Hosted by the National Organization...
Accelerating the Cure: IWMF Launches 2026 Research RFPs for WM
Accelerating the Cure: IWMF Launches 2026 Research RFPs for WM The International Waldenstrom Macroglobulinemia Foundation (IWMF) is pleased to partner with Blood Cancer United (formerly Leukemia & Lymphoma Society) to announce the launch of our 2026 Research...
Into the world—Welcome Bexobrutideg!
Accelerate the Cure Into the world—Welcome Bexobrutideg! We recently wrote about a new type of drug—a BTK degrader— that emerged in 2024, for phase one trials at Nurix Therapeutics and BeOne. The Nurix trial earned FDA fast-track status in December. In a short three...
Discover the 2024 IWMF Annual Report – Progress, Hope, and a Path to a Cure
If you have Waldenstrom’s macroglobulinemia (WM), care for someone who does, or simply believe in the power of research, you’ll want to read the 2024 IWMF Annual Report. This year’s report highlights how the International Waldenstrom’s Macroglobulinemia Foundation...
The Next Big Thing? Protein BTK Degraders
We are encouraged and excited to share ground-breaking news from Nurix Therapeutics, a pharmaceutical partner in WM-NET, our growing network of 22 US research institutions coordinating Waldenstrom’s macroglobulinemia (WM) clinical trials, supported by Accelerate...
Thank You! The 2025 WM Giving Challenge.
Thank You for Helping Us Accelerate the Cure! A big thank-you to everyone in the IWMF community who supported Accelerate the Cure during our Global Challenge Research Tour! We had 1,291 people visit a research lab during the Tour. About 25% of them used our French,...